Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Scinai Immunotherapeutics Ltd ADR
(NQ:
SCNI
)
3.020
UNCHANGED
Streaming Delayed Price
Updated: 3:59 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Scinai Immunotherapeutics Ltd ADR
< Previous
1
2
3
4
5
Next >
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Receive $900K IIA Grant for New CDMO Business Unit
November 07, 2023
Via
Investor Brand Network
Topics
Economy
Exposures
Economy
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Releases Status Report on NASDAQ Compliance
November 06, 2023
Via
Investor Brand Network
Scinai Immunotherapeutics Announces Award of Non-Dilutive Grant from Israel Innovation Authority Supporting its New CDMO Business Unit
November 06, 2023
From
Scinai Immunotherapeutics Ltd.
Via
GlobeNewswire
Potential Complications of Untreated Psoriasis
November 02, 2023
Via
Investor Brand Network
Scinai Immunotherapeutics Provides Update Regarding Nasdaq Compliance
November 03, 2023
From
Scinai Immunotherapeutics Ltd.
Via
GlobeNewswire
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Releases Q3 2023 Financial Report, Reports Possible Adjustment of Facility Terms by EIB
October 31, 2023
Via
Investor Brand Network
Exposures
COVID-19
European Investment Bank (EIB) considering extending maturity of its financial facility contract with Scinai Immunotherapeutics in light of Scinai’s recent strategic pivot
October 31, 2023
From
Scinai Immunotherapeutics Ltd.
Via
GlobeNewswire
Scinai Reports Third Quarter 2023 Financial Results and Provides Business Update
October 31, 2023
From
Scinai Immunotherapeutics Ltd.
Via
GlobeNewswire
Study Identifies Immune Cells Responsible for Severe Asthma
October 30, 2023
Via
Investor Brand Network
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announces Participation at BIO-Europe Munich 2023
October 30, 2023
Via
Investor Brand Network
Scinai Immunotherapeutics to Attend BIO-Europe Munich 2023
October 30, 2023
From
Scinai Immunotherapeutics Ltd.
Via
GlobeNewswire
Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) to Showcase Its Boutique End-to-End CDMO Services at the Premier CPHI Barcelona Event
October 27, 2023
Via
Investor Brand Network
Five Ways to Treat Infectious Diseases While Keeping Antimicrobial Resistance in Check
October 23, 2023
Via
Investor Brand Network
Exposures
COVID-19
Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports Promising Results in Its Pursuit of Safe, Effective Treatments for Large, Underserved Population of Plaque Psoriasis Patients
October 23, 2023
Via
Investor Brand Network
Researchers ID Biomarker That Could Improve Autoimmune Disease Treatment
October 17, 2023
Via
Investor Brand Network
12 Health Care Stocks Moving In Thursday's After-Market Session
October 12, 2023
Via
Benzinga
Syndromic Testing Could Transform Infectious Disease Diagnosis
October 11, 2023
Via
Investor Brand Network
Exposures
COVID-19
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 10, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
October 09, 2023
Via
Benzinga
Researchers Find Psoriasis Increases Risk of Heart Disease
October 05, 2023
Via
Investor Brand Network
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announces Participation at CPHI Barcelona 2023, Other Upcoming Events
October 04, 2023
Via
Investor Brand Network
Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Secures $1.33 Million from Registered Direct Offering to Boost Commercial Development
October 04, 2023
Via
Investor Brand Network
Scinai Immunotherapeutics to Showcase its end-to-end cGMP Biologics CDMO Services at CPHI Barcelona 2023
October 04, 2023
Targeting biotech companies with drug production process development and optimization, analytical methods development, and GMP production for clinical trials
From
Scinai Immunotherapeutics Ltd.
Via
GlobeNewswire
Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Finalizes Rebrand to Reflect New Strategic Direction, Diversification
October 02, 2023
Via
Investor Brand Network
CDC Avails $262M to New Network Aimed at Responding to Future Disease Outbreaks
September 29, 2023
Via
Investor Brand Network
Inverse Vaccines Show Promise Against Autoimmunity
September 25, 2023
Via
Investor Brand Network
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Closes on $1.33M Registered Direct Offering
September 20, 2023
Via
Investor Brand Network
Scinai Immunotherapeutics Announces Closing of $1.33 Million Registered Direct Offering
September 19, 2023
From
Scinai Immunotherapeutics Ltd.
Via
GlobeNewswire
Study Shows Climate Change Impacts Infectious Disease Risks
September 19, 2023
Via
Investor Brand Network
Topics
Climate Change
Exposures
Climate
Why Novonix Shares Are Trading Higher By 27%? Here Are Other Stocks Moving In Friday's Mid-Day Session
September 15, 2023
Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 127.8% to $0.1269. The company recently reported second-quarter results.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
